Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 3:27 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 985–1008 of 3,580 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: patch Clear all

Conditions: Overactive Bladder
Interventions: (VERV™ System), Sham version of (VERV™ System); Device
Lead sponsor: Ethicon Endo-Surgery; Industry
Eligibility: 18 Years and older
Enrollment: 163 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 14
States / cities: Tucson, Arizona • Murrieta, California • Washington D.C., District of Columbia + 11 more

Conditions: Smoking, Pregnancy
Interventions: Motivational interviewing for smoking cessation, Cognitive behaviors therapy, CBT + NRT; Behavioral · Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 181 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2003
U.S. locations: 2
States / cities: Durham, North Carolina • Fayetteville, North Carolina

Conditions: Peripheral Vascular Diseases
Interventions: Treatment with the GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface; Device
Lead sponsor: W.L.Gore & Associates; Industry
Eligibility: 18 Years and older
Enrollment: 119 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 5
States / cities: Oceanside, California • Chicago, Illinois • Columbia, Missouri + 2 more

Conditions: Tobacco Use, Tobacco Smoking, Tobacco Use Cessation, Tobacco Use Disorder, Schizophrenia, Schizoaffective Disorder
Interventions: Persistence Targeted Smoking Cessation in SMI (PTSC-S), Nicotine patch; Behavioral · Drug
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years to 70 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Actinic Keratosis
Interventions: Metvix-PDT, Vehicle-PDT; Combination Product
Lead sponsor: Galderma R&D; Industry
Eligibility: 18 Years and older
Enrollment: 131 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 4
States / cities: Naperville, Illinois • Louisville, Kentucky • Portland, Oregon + 1 more

Conditions: Prostate Cancer
Interventions: Exablate Prostate Treatment; Device
Lead sponsor: InSightec; Industry
Eligibility: 50 Years and older · Male only
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 5
States / cities: Stanford, California • Delray Beach, Florida • Boston, Massachusetts + 2 more

Conditions: Coronary Artery Disease
Interventions: Resolute Integrity Stent; Device
Lead sponsor: Medtronic Vascular; Industry
Eligibility: 18 Years and older
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: Rotator Cuff Tears, Shoulder Surgery
Interventions: Regeneten Collagen Patch; Device
Lead sponsor: Rothman Institute Orthopaedics; Other
Eligibility: 40 Years to 75 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Cardiovascular Risk Factor
Interventions: No to Low Endogenous Estrogen, Estradiol; Other
Lead sponsor: University of Delaware; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Menopause, Postmenopause, Premenopause, Cardiovascular Disease
Interventions: transdermal estradiol patch (Vivelle), oral estrogen (Estrace), progesterone (Prometrium); Drug
Lead sponsor: Northwestern University; Other
Eligibility: 47 Years to 55 Years · Female only
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1998 – 2005
U.S. locations: 2
States / cities: Chicago, Illinois • Seattle, Washington

Conditions: Urticaria, Patch Testing, Dermatitis, Allergy, Contact Sensitization
Interventions: Patch Testing; Procedure
Lead sponsor: Tufts Medical Center; Other
Eligibility: Not listed
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Contraception, Bleeding
Interventions: transdermal estradiol, naproxen, oral placebo; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 129 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Dermatitis, Atopic
Interventions: Nanodox 1% (doxycycline monohydrate hydrogel); Drug
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 65 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 2
States / cities: Gainesville, Florida

Conditions: Pancreatic Cancer
Interventions: Not listed
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2030
U.S. locations: 1
States / cities: New York, New York

Conditions: Erythema
Interventions: MOB015B, 0.2% SLS, 0.9% Saline, MOB015B vehicle; Drug
Lead sponsor: Moberg Pharma AB; Industry
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Fair Lawn, New Jersey

Conditions: Healthy
Interventions: Microneedle patch; Device
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years to 50 Years
Enrollment: 132 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Pain on IV Injection of Propofol.
Interventions: Lidocaine/tetracaine transdermal patch, Saline, Lidocaine; Device · Drug
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 6 Years to 17 Years
Enrollment: 76 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Psoriasis
Interventions: Skin biopsy, Blood draw; Procedure
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Early-Stage Parkinson's Disease
Interventions: Rotigotine; Drug
Lead sponsor: UCB Pharma; Industry
Eligibility: 31 Years and older
Enrollment: 217 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2008
U.S. locations: 37
States / cities: Peoria, Arizona • Phoenix, Arizona • Tucson, Arizona + 34 more

Conditions: Pandemic Influenza
Interventions: A/H5N1, Placebo; Biological
Lead sponsor: Intercell USA, Inc.; Industry
Eligibility: 18 Years to 49 Years
Enrollment: 501 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 5
States / cities: Vallejo, California • Miami, Florida • Kansas City, Kansas + 2 more

Conditions: Mid-membranous Vocal Fold Lesion
Interventions: Resonant voice therapy; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 40 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Peripheral Arterial Disease, Claudication
Interventions: Visi-Pro™ Balloon Expandable Stent System; Device
Lead sponsor: Medtronic Endovascular; Industry
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Teaneck, New Jersey

Conditions: Nicotine Addiction, Serious Mental Illness
Interventions: Learn to Quit App, Nicotine patch, Nicotine lozenge, Technical Coaching, NCI QuitGuide App; Device · Drug · Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Tobacco Dependence
Interventions: C-Raven Virtual Tobacco Cessation Counseling, Nicotine Replacement Product, Community Health Worker, Lung Cancer Screening; Behavioral · Drug · Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 50 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Search by objective public record fields.

Safety and Effectiveness of a Non-invasive Neuromodulation Device on Urgency Urinary Incontinence in Overactive Bladder

Testing Pharmacological Therapies for Pregnant Smokers

GORE VIABAHN Endoprosthesis With Heparin Bioactive Surface in the Treatment of SFA Obstructive Disease (VIPER)

Persistence Targeted Smoking Cessation in Serious Mental Illness (SMI)

Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp

Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate Lesions

Resolute Integrity US Extended Length Sub-Study(RI US XL)

Regeneten Patch vs Standard Care in Partial Thickness Rotator Cuff Repair

Menopause Effects on Vascular Function

Midlife Cholesterol Study

Evaluating for Contact Allergies in Patients With Chronic Urticaria

A Randomized Controlled Trial of Oral Naproxen and Transdermal Estradiol for Bleeding in LNG-IUC

Topical NanoDox® for Atopic Dermatitis

PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease

Skin Irritation Potential of MOB015B in Healthy Subjects Using a Cumulative Irritant Patch Test Design

Racial/Ethnic Differences in Microneedle Response

Combining Placing a Synera Patch With Propofol/Lidocaine Mixture to Decrease Pain With IV Propofol Injection

Single Cell Genomics of Psoriatic Skin

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease.

A/H5N1 Dose Ranging Study With Adjuvant Patch

Laryngeal and Vocal Tract Strategies to Reduce Vocal Fold Contact Pressure

VISIBILITY™ Iliac Study

Feasibility Trial of a Tailored Smoking Cessation App for People With Serious Mental Illness

C-Raven, a Virtual Tobacco Cessation Intervention in Residency Clinics